Last Modified: March 21, 2014
Dates: June 6, 2014
Location: Smilow Center for Translational Research Auditorium, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd., Philadelphia, PA 19104
Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania
Web Page URL: penncancer.org/CME/Brain
Topics Covered: Minimally Invasive Skull-Base Surgery Radiation Therapy: Proton, Stereotactic Intensity Modulated, Cyber/Gamma Knife Systemic and Targeted Therapies Treatment of Metastatic Brain Tumors Functional Imaging Survivorship: Seizure Management and Neurocognition Anti-angiogenesis Personalized Diagnostics Clinician's Perspective of Precision Medicine Immunotherapy Clinical Trials T-Cell Immunotherapy for Brain Tumors Vaccines New Drug Discovery
Objectives: Upon completion of this symposium, participants should be able to:
Who Should Attend: This symposium is designed for neurosurgeons, neuro-oncologists, neurologists, radiologists, medical oncologists, radiation oncologists, pathologists, neuropsychologists, primary care physicians, oncology nurses, and other healthcare professionals involved in the treatment of patients with brain tumors.
Registration Information: To request a brochure, please contact Mary M. Graham at email@example.com
Fees: $50 Practicing Physician; $25 non-Penn resident, fellow, nurse, and other healthcare professional; $25 faculty, staff, resident, fellow and/or student of the University of Pennsylvania
Continuing Education: Yes
Miscellany: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.